老虎證券

美股詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務

CNS Pharmaceuticals, Inc.

5.18
-0.3200-5.82%
成交量：74
成交額：377.97
市值：757.00萬
市盈率：-0.22
高：5.18
開：5.18
低：5.18
收：5.50
52周最高：10.59
52周最低：1.90
股本：146.14萬
流通股本：135.46萬
量比：1.07
換手率：0.01%
股息：- -
股息率：- -
每股收益(TTM):-23.1416
每股收益(LYR):-35.7503
淨資產收益率：-106.62%
總資產收益率：-58.01%
市淨率：0.42
市盈率(LYR):-0.14

資料載入中...

總覽公司新聞資訊公告
2021/02/16

[修訂]年度報告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/12

重要事件披露

8-K - Current report
2021/02/12

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/01

SEC問詢函

CORRESP [Cover] - Correspondence
2021/01/07

重要事件披露

8-K - Current report
2020/12/28

重要事件披露

8-K - Current report
2020/12/22

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/12/21

SEC問詢函

CORRESP [Cover] - Correspondence
2020/12/21

SEC問詢函

CORRESP [Cover] - Correspondence
2020/12/21

重要事件披露

8-K - Current report
2020/12/21

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2020/12/11

重要事件披露

8-K - Current report
2020/11/12

重要事件披露

8-K - Current report
2020/11/12

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/10/02

SEC問詢函

CORRESP [Cover] - Correspondence
2020/09/25

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2020/09/21

重要事件披露

8-K - Current report
2020/09/16

重要事件披露

8-K/A [Amend] - Current report
2020/09/16

重要事件披露

8-K - Current report
2020/09/04

重要事件披露

8-K - Current report
更多